| |
|
|
|
Adamas Pharma  
|
|
5.16 0.28 (0.06%) |
09-28 16:00 |
|
Open: |
5.14 |
Pre close: |
4.88 |
Target:
|
6.11
|
|
High: |
5.2 |
Low: |
5.01 |
Resistance:
|
5.24
6.11
|
|
Volume: |
193,789 |
Market Cap: |
234M |
Support:
|
4.73
 4.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.97
|
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
4.76 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
4.96 |
Stochastic Oscillator |
%K(14,3):
|
84.80 |
|
MA(250): |
4.88 |
%D(3): |
75.50 |
|
Average Volume(K) |
3-Month: |
22917
|
52-Week |
High:
|
9.15 |
|
10-Days: |
20449 |
Low: |
2.96 |
|
RSI |
RSI(14):
|
62.61  |
Change(%): |
25.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.770 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
45.41 |
|
EPS Est. Current Year |
-3.770 |
Return on Assets (ttm) |
-14.1 |
Shares Float (M) |
33.03 |
|
EPS Est. Next Year |
-3.420 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.41 |
|
EPS Est. Next Quarter |
-1.170 |
Qtrly Rev. Growth |
33.4 |
% Held by Institutions |
78.21 |
|
Forward EPS |
-3.800 |
Gross Profit (p.s.) |
1.595 |
Shares Short (K) |
2210 |
|
Book Value (p.s.) |
0.130 |
EBITDA (p.s.) |
-0.763 |
P/E |
-2.92 |
|
Sales Per Share |
1.746 |
Qtrly Earnings Growth |
0.00 |
P/BV |
39.69 |
|
Profit Margin |
-67.26 |
Operating Cash Flow
(M) |
-54.46 |
P/S |
2.95 |
|
Operating Margin |
-44.62 |
Levered Free Cash Flow
(M) |
-33.54 |
P/CF |
-4.30 |
|
|
|
|
|
|
